NewsBenzingaTakeda Pharmaceutical Co Raises FY2026 GAAP EPS Guidance from JPY 104 to JPY 131 Takeda Pharmaceutical Co Raises FY2026 GAAP EPS Guidance from JPY 104 to JPY 131 Benzinga 2026.10.29 07:56 (GMT+0) Open on Benzinga Other news Building A 7%-Yielding Dividend Growth Portfolio With SCHD As Its Core Holding Lilly raises outlook for third time this year as Zepbound sales soar WPP plc (WPP) Q3 2026 Sales/ Trading Statement Call - Slideshow (NYSE:WPP) 2026-10-29 AutoZone's Q1 2027 Earnings: What to Expect Shopify Bull Put Spread Could Return 25% Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
